0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gonadorelin for Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17X15271
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gonadorelin for Injection Market Research Report 2023
BUY CHAPTERS

Global Gonadorelin for Injection Market Research Report 2025

Code: QYRE-Auto-17X15271
Report
May 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gonadorelin for Injection Market

The global market for Gonadorelin for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The indications for gonadorelin for injection are that this product is suitable for the differential diagnosis of male or female fertility disorders caused by hypothalamic or pituitary hypofunction, gonadal atrophic hypogonadism, galactorrhea amenorrhea, primary and secondary Sexual amenorrhea, menopause and precocious menopause, pituitary tumors, organ damage to the pituitary gland, and de facto hypothalamic dysfunction.
North American market for Gonadorelin for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gonadorelin for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Gonadorelin for Injection include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON, Ipsen, Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gonadorelin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonadorelin for Injection.
The Gonadorelin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gonadorelin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonadorelin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gonadorelin for Injection Market Report

Report Metric Details
Report Name Gonadorelin for Injection Market
Segment by Type
  • 100μg/ml
  • 200μg/ml
  • 300μg/ml
  • 400μg/ml
  • 500μg/ml
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON, Ipsen, Sanofi, Endo, Tocris Bioscience, Sigma-Aldrich, MedChem Express, Arbor Pharmaceuticals, ESTEVE, Anhui Fengyuan Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gonadorelin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gonadorelin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gonadorelin for Injection Market report?

Ans: The main players in the Gonadorelin for Injection Market are Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON, Ipsen, Sanofi, Endo, Tocris Bioscience, Sigma-Aldrich, MedChem Express, Arbor Pharmaceuticals, ESTEVE, Anhui Fengyuan Pharmaceutical

What are the Application segmentation covered in the Gonadorelin for Injection Market report?

Ans: The Applications covered in the Gonadorelin for Injection Market report are Patients With Fertility Disorders, Patients With Endocrine Disorders, Others

What are the Type segmentation covered in the Gonadorelin for Injection Market report?

Ans: The Types covered in the Gonadorelin for Injection Market report are 100μg/ml, 200μg/ml, 300μg/ml, 400μg/ml, 500μg/ml, Others

Recommended Reports

Hormone Therapy Markets

Reproductive Health Markets

Injection and Endocrine Drugs

1 Gonadorelin for Injection Market Overview
1.1 Product Definition
1.2 Gonadorelin for Injection by Type
1.2.1 Global Gonadorelin for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100μg/ml
1.2.3 200μg/ml
1.2.4 300μg/ml
1.2.5 400μg/ml
1.2.6 500μg/ml
1.2.7 Others
1.3 Gonadorelin for Injection by Application
1.3.1 Global Gonadorelin for Injection Market Value by Application (2024 VS 2031)
1.3.2 Patients With Fertility Disorders
1.3.3 Patients With Endocrine Disorders
1.3.4 Others
1.4 Global Gonadorelin for Injection Market Size Estimates and Forecasts
1.4.1 Global Gonadorelin for Injection Revenue 2020-2031
1.4.2 Global Gonadorelin for Injection Sales 2020-2031
1.4.3 Global Gonadorelin for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gonadorelin for Injection Market Competition by Manufacturers
2.1 Global Gonadorelin for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gonadorelin for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gonadorelin for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gonadorelin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gonadorelin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadorelin for Injection, Product Type & Application
2.7 Global Key Manufacturers of Gonadorelin for Injection, Date of Enter into This Industry
2.8 Global Gonadorelin for Injection Market Competitive Situation and Trends
2.8.1 Global Gonadorelin for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gonadorelin for Injection Players Market Share by Revenue
2.8.3 Global Gonadorelin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gonadorelin for Injection Market Scenario by Region
3.1 Global Gonadorelin for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gonadorelin for Injection Sales by Region: 2020-2031
3.2.1 Global Gonadorelin for Injection Sales by Region: 2020-2025
3.2.2 Global Gonadorelin for Injection Sales by Region: 2026-2031
3.3 Global Gonadorelin for Injection Revenue by Region: 2020-2031
3.3.1 Global Gonadorelin for Injection Revenue by Region: 2020-2025
3.3.2 Global Gonadorelin for Injection Revenue by Region: 2026-2031
3.4 North America Gonadorelin for Injection Market Facts & Figures by Country
3.4.1 North America Gonadorelin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gonadorelin for Injection Sales by Country (2020-2031)
3.4.3 North America Gonadorelin for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadorelin for Injection Market Facts & Figures by Country
3.5.1 Europe Gonadorelin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gonadorelin for Injection Sales by Country (2020-2031)
3.5.3 Europe Gonadorelin for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadorelin for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Gonadorelin for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gonadorelin for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Gonadorelin for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gonadorelin for Injection Market Facts & Figures by Country
3.7.1 Latin America Gonadorelin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gonadorelin for Injection Sales by Country (2020-2031)
3.7.3 Latin America Gonadorelin for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gonadorelin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadorelin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gonadorelin for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gonadorelin for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gonadorelin for Injection Sales by Type (2020-2031)
4.1.1 Global Gonadorelin for Injection Sales by Type (2020-2025)
4.1.2 Global Gonadorelin for Injection Sales by Type (2026-2031)
4.1.3 Global Gonadorelin for Injection Sales Market Share by Type (2020-2031)
4.2 Global Gonadorelin for Injection Revenue by Type (2020-2031)
4.2.1 Global Gonadorelin for Injection Revenue by Type (2020-2025)
4.2.2 Global Gonadorelin for Injection Revenue by Type (2026-2031)
4.2.3 Global Gonadorelin for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Gonadorelin for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gonadorelin for Injection Sales by Application (2020-2031)
5.1.1 Global Gonadorelin for Injection Sales by Application (2020-2025)
5.1.2 Global Gonadorelin for Injection Sales by Application (2026-2031)
5.1.3 Global Gonadorelin for Injection Sales Market Share by Application (2020-2031)
5.2 Global Gonadorelin for Injection Revenue by Application (2020-2031)
5.2.1 Global Gonadorelin for Injection Revenue by Application (2020-2025)
5.2.2 Global Gonadorelin for Injection Revenue by Application (2026-2031)
5.2.3 Global Gonadorelin for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Gonadorelin for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Gonadorelin for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AbbVie Gonadorelin for Injection Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Gonadorelin for Injection Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Ferring
6.4.1 Ferring Company Information
6.4.2 Ferring Description and Business Overview
6.4.3 Ferring Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ferring Gonadorelin for Injection Product Portfolio
6.4.5 Ferring Recent Developments/Updates
6.5 TerSera Therapeutics
6.5.1 TerSera Therapeutics Company Information
6.5.2 TerSera Therapeutics Description and Business Overview
6.5.3 TerSera Therapeutics Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TerSera Therapeutics Gonadorelin for Injection Product Portfolio
6.5.5 TerSera Therapeutics Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Company Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Astellas Pharma Gonadorelin for Injection Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 Takeda
6.7.1 Takeda Company Information
6.7.2 Takeda Description and Business Overview
6.7.3 Takeda Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Gonadorelin for Injection Product Portfolio
6.7.5 Takeda Recent Developments/Updates
6.8 LIVZON
6.8.1 LIVZON Company Information
6.8.2 LIVZON Description and Business Overview
6.8.3 LIVZON Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LIVZON Gonadorelin for Injection Product Portfolio
6.8.5 LIVZON Recent Developments/Updates
6.9 Ipsen
6.9.1 Ipsen Company Information
6.9.2 Ipsen Description and Business Overview
6.9.3 Ipsen Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ipsen Gonadorelin for Injection Product Portfolio
6.9.5 Ipsen Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Company Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi Gonadorelin for Injection Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Endo
6.11.1 Endo Company Information
6.11.2 Endo Description and Business Overview
6.11.3 Endo Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Endo Gonadorelin for Injection Product Portfolio
6.11.5 Endo Recent Developments/Updates
6.12 Tocris Bioscience
6.12.1 Tocris Bioscience Company Information
6.12.2 Tocris Bioscience Description and Business Overview
6.12.3 Tocris Bioscience Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tocris Bioscience Gonadorelin for Injection Product Portfolio
6.12.5 Tocris Bioscience Recent Developments/Updates
6.13 Sigma-Aldrich
6.13.1 Sigma-Aldrich Company Information
6.13.2 Sigma-Aldrich Description and Business Overview
6.13.3 Sigma-Aldrich Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sigma-Aldrich Gonadorelin for Injection Product Portfolio
6.13.5 Sigma-Aldrich Recent Developments/Updates
6.14 MedChem Express
6.14.1 MedChem Express Company Information
6.14.2 MedChem Express Description and Business Overview
6.14.3 MedChem Express Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MedChem Express Gonadorelin for Injection Product Portfolio
6.14.5 MedChem Express Recent Developments/Updates
6.15 Arbor Pharmaceuticals
6.15.1 Arbor Pharmaceuticals Company Information
6.15.2 Arbor Pharmaceuticals Description and Business Overview
6.15.3 Arbor Pharmaceuticals Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Arbor Pharmaceuticals Gonadorelin for Injection Product Portfolio
6.15.5 Arbor Pharmaceuticals Recent Developments/Updates
6.16 ESTEVE
6.16.1 ESTEVE Company Information
6.16.2 ESTEVE Description and Business Overview
6.16.3 ESTEVE Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.16.4 ESTEVE Gonadorelin for Injection Product Portfolio
6.16.5 ESTEVE Recent Developments/Updates
6.17 Anhui Fengyuan Pharmaceutical
6.17.1 Anhui Fengyuan Pharmaceutical Company Information
6.17.2 Anhui Fengyuan Pharmaceutical Description and Business Overview
6.17.3 Anhui Fengyuan Pharmaceutical Gonadorelin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Anhui Fengyuan Pharmaceutical Gonadorelin for Injection Product Portfolio
6.17.5 Anhui Fengyuan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gonadorelin for Injection Industry Chain Analysis
7.2 Gonadorelin for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadorelin for Injection Production Mode & Process Analysis
7.4 Gonadorelin for Injection Sales and Marketing
7.4.1 Gonadorelin for Injection Sales Channels
7.4.2 Gonadorelin for Injection Distributors
7.5 Gonadorelin for Injection Customer Analysis
8 Gonadorelin for Injection Market Dynamics
8.1 Gonadorelin for Injection Industry Trends
8.2 Gonadorelin for Injection Market Drivers
8.3 Gonadorelin for Injection Market Challenges
8.4 Gonadorelin for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Gonadorelin for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gonadorelin for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gonadorelin for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gonadorelin for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gonadorelin for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gonadorelin for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gonadorelin for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gonadorelin for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gonadorelin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gonadorelin for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gonadorelin for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Gonadorelin for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gonadorelin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadorelin for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gonadorelin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gonadorelin for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gonadorelin for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Gonadorelin for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gonadorelin for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Gonadorelin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gonadorelin for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Gonadorelin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gonadorelin for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Gonadorelin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gonadorelin for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gonadorelin for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gonadorelin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gonadorelin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gonadorelin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gonadorelin for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gonadorelin for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gonadorelin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gonadorelin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gonadorelin for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gonadorelin for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gonadorelin for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gonadorelin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gonadorelin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gonadorelin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gonadorelin for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gonadorelin for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gonadorelin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gonadorelin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gonadorelin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gonadorelin for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gonadorelin for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gonadorelin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gonadorelin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gonadorelin for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Gonadorelin for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Gonadorelin for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Gonadorelin for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Gonadorelin for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gonadorelin for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gonadorelin for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Gonadorelin for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Gonadorelin for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Gonadorelin for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Gonadorelin for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Gonadorelin for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Gonadorelin for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Gonadorelin for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Gonadorelin for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gonadorelin for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gonadorelin for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Gonadorelin for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Gonadorelin for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Gonadorelin for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Gonadorelin for Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AbbVie Gonadorelin for Injection Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Gonadorelin for Injection Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Ferring Company Information
 Table 86. Ferring Description and Business Overview
 Table 87. Ferring Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ferring Gonadorelin for Injection Product
 Table 89. Ferring Recent Developments/Updates
 Table 90. TerSera Therapeutics Company Information
 Table 91. TerSera Therapeutics Description and Business Overview
 Table 92. TerSera Therapeutics Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. TerSera Therapeutics Gonadorelin for Injection Product
 Table 94. TerSera Therapeutics Recent Developments/Updates
 Table 95. Astellas Pharma Company Information
 Table 96. Astellas Pharma Description and Business Overview
 Table 97. Astellas Pharma Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Astellas Pharma Gonadorelin for Injection Product
 Table 99. Astellas Pharma Recent Developments/Updates
 Table 100. Takeda Company Information
 Table 101. Takeda Description and Business Overview
 Table 102. Takeda Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Takeda Gonadorelin for Injection Product
 Table 104. Takeda Recent Developments/Updates
 Table 105. LIVZON Company Information
 Table 106. LIVZON Description and Business Overview
 Table 107. LIVZON Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. LIVZON Gonadorelin for Injection Product
 Table 109. LIVZON Recent Developments/Updates
 Table 110. Ipsen Company Information
 Table 111. Ipsen Description and Business Overview
 Table 112. Ipsen Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Ipsen Gonadorelin for Injection Product
 Table 114. Ipsen Recent Developments/Updates
 Table 115. Sanofi Company Information
 Table 116. Sanofi Description and Business Overview
 Table 117. Sanofi Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sanofi Gonadorelin for Injection Product
 Table 119. Sanofi Recent Developments/Updates
 Table 120. Endo Company Information
 Table 121. Endo Description and Business Overview
 Table 122. Endo Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Endo Gonadorelin for Injection Product
 Table 124. Endo Recent Developments/Updates
 Table 125. Tocris Bioscience Company Information
 Table 126. Tocris Bioscience Description and Business Overview
 Table 127. Tocris Bioscience Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Tocris Bioscience Gonadorelin for Injection Product
 Table 129. Tocris Bioscience Recent Developments/Updates
 Table 130. Sigma-Aldrich Company Information
 Table 131. Sigma-Aldrich Description and Business Overview
 Table 132. Sigma-Aldrich Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Sigma-Aldrich Gonadorelin for Injection Product
 Table 134. Sigma-Aldrich Recent Developments/Updates
 Table 135. MedChem Express Company Information
 Table 136. MedChem Express Description and Business Overview
 Table 137. MedChem Express Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. MedChem Express Gonadorelin for Injection Product
 Table 139. MedChem Express Recent Developments/Updates
 Table 140. Arbor Pharmaceuticals Company Information
 Table 141. Arbor Pharmaceuticals Description and Business Overview
 Table 142. Arbor Pharmaceuticals Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Arbor Pharmaceuticals Gonadorelin for Injection Product
 Table 144. Arbor Pharmaceuticals Recent Developments/Updates
 Table 145. ESTEVE Company Information
 Table 146. ESTEVE Description and Business Overview
 Table 147. ESTEVE Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. ESTEVE Gonadorelin for Injection Product
 Table 149. ESTEVE Recent Developments/Updates
 Table 150. Anhui Fengyuan Pharmaceutical Company Information
 Table 151. Anhui Fengyuan Pharmaceutical Description and Business Overview
 Table 152. Anhui Fengyuan Pharmaceutical Gonadorelin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Anhui Fengyuan Pharmaceutical Gonadorelin for Injection Product
 Table 154. Anhui Fengyuan Pharmaceutical Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Gonadorelin for Injection Distributors List
 Table 158. Gonadorelin for Injection Customers List
 Table 159. Gonadorelin for Injection Market Trends
 Table 160. Gonadorelin for Injection Market Drivers
 Table 161. Gonadorelin for Injection Market Challenges
 Table 162. Gonadorelin for Injection Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gonadorelin for Injection
 Figure 2. Global Gonadorelin for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gonadorelin for Injection Market Share by Type: 2024 & 2031
 Figure 4. 100μg/ml Product Picture
 Figure 5. 200μg/ml Product Picture
 Figure 6. 300μg/ml Product Picture
 Figure 7. 400μg/ml Product Picture
 Figure 8. 500μg/ml Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Gonadorelin for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Gonadorelin for Injection Market Share by Application: 2024 & 2031
 Figure 12. Patients With Fertility Disorders
 Figure 13. Patients With Endocrine Disorders
 Figure 14. Others
 Figure 15. Global Gonadorelin for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Gonadorelin for Injection Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Gonadorelin for Injection Sales (2020-2031) & (K Units)
 Figure 18. Global Gonadorelin for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 19. Gonadorelin for Injection Report Years Considered
 Figure 20. Gonadorelin for Injection Sales Share by Manufacturers in 2024
 Figure 21. Global Gonadorelin for Injection Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Gonadorelin for Injection Players: Market Share by Revenue in Gonadorelin for Injection in 2024
 Figure 23. Gonadorelin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Gonadorelin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Gonadorelin for Injection Sales Market Share by Country (2020-2031)
 Figure 26. North America Gonadorelin for Injection Revenue Market Share by Country (2020-2031)
 Figure 27. United States Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Gonadorelin for Injection Sales Market Share by Country (2020-2031)
 Figure 30. Europe Gonadorelin for Injection Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Gonadorelin for Injection Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Gonadorelin for Injection Revenue Market Share by Region (2020-2031)
 Figure 38. China Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Gonadorelin for Injection Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Gonadorelin for Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Gonadorelin for Injection Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Gonadorelin for Injection Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Gonadorelin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Gonadorelin for Injection by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Gonadorelin for Injection by Type (2020-2031)
 Figure 57. Global Gonadorelin for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Gonadorelin for Injection by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Gonadorelin for Injection by Application (2020-2031)
 Figure 60. Global Gonadorelin for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 61. Gonadorelin for Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart